Potential Impact of Cyclodextrin-Containing Formulations in Toxicity Evaluation of Novel Compounds in Early Drug Discovery

Journal Title: Journal of Pharmaceutics & Pharmacology - Year 2014, Vol 2, Issue 1

Abstract

Cyclodextrins (CDs) are widely used as enabling excipients to improve in vivo drug delivery. The ability of CDs to form inclusion complexes with drugs and thereby improving solubility and stability of drugs is well established, and has been successfully used for several drugs on the market. Combined with well established preclinical and clinical safety profiles for selected CDs, they are of interest as excipients in preclinical and clinical stages of drug development. Another feature of CDs is their demonstrated ability to mitigate local toxicities of drugs. While this feature makes them attractive from a clinical drug delivery perspective, it may not be ideal from a preclinical toxicology evaluation perspective when the new chemical entities have intrinsic irritant or cytotoxic characteristics, which may be shielded by CDs. Herein, we review use of CDs in pharmaceuticals, focusing on their potential to mitigate toxicities of compounds, and suggest that, this very potential may undermine toxicity evaluation, especially by oral route, of novel compounds during early drug discovery.

Authors and Affiliations

Umesh M Hanumegowda

Keywords

Related Articles

Invitro and Invivo Inhibition of Metyrapone metabolism by Glycyrrhetinic Acid in Male Wistar Rats

Objectives: We investigated the inhibitory effect of glycyrrhetinic acid (GA), an 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, on the reductive metabolism of metyrapone (MP) in an invitro study, and the...

Development of Controlled- Release Solid Dispersion Granules Containing a Poorly Water-Soluble Drug, Porous Calcium Silicate, and the Water-Soluble Polymer Polyvinylpyrrolidone

Objectives: This study sought to develop controlled-release solid dispersion granules containing a poorly water-soluble drug, porous calcium silicate (PCS), and a water-soluble polymer. Methods: Nifedipine (NIF) and ind...

QbD Based Approach to Design Controlled Strategy for Wet Granulation Method Using Plackett Burman Design-Case Study

Objective: The objective of present work describes developing controlled strategy for wet granulation process by identifying critical process parameters and study was done using DoE in support of Quality by Design (QbD)....

Reactive Oxygen Species as β2-Adrenergic Receptor Signal Transducers

Reactive oxygen species (ROS), which include superoxide (O2−), hydrogen peroxide (H2O2), and the hydroxyl radical (OH.), have traditionally been cast as cellular byproducts, having benefit only for their microbicidal pro...

Eribis Peptide 94 Mimics Ischemic Preconditioning in Rats with an Acute Myocardial Infarction and has Cardioprotective Effects during Prolonged Ischemia

Objectives: Previously, we demonstrated that a novel enkephalin analogue, Eribis Peptide 94 (EP94), produces a reduction of myocardial infarct size in rats and pigs administrated during occlusion. Since a complete dose-r...

Download PDF file
  • EP ID EP197899
  • DOI 10.13188/2327-204X.1000006
  • Views 92
  • Downloads 0

How To Cite

Umesh M Hanumegowda (2014). Potential Impact of Cyclodextrin-Containing Formulations in Toxicity Evaluation of Novel Compounds in Early Drug Discovery. Journal of Pharmaceutics & Pharmacology, 2(1), 1-5. https://europub.co.uk/articles/-A-197899